Key statistics
As of last trade AxoGen Inc (AXGN:NAQ) traded at 29.75, -17.37% below its 52-week high of 36.00, set on Feb 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 30.18 |
|---|---|
| High | 30.49 |
| Low | 29.37 |
| Bid | 29.68 |
| Offer | 29.77 |
| Previous close | 29.83 |
| Average volume | 1.15m |
|---|---|
| Shares outstanding | 51.90m |
| Free float | 49.53m |
| P/E (TTM) | -- |
| Market cap | 1.55bn USD |
| EPS (TTM) | -0.3413 USD |
Data delayed at least 15 minutes, as of Mar 04 2026 16:31 GMT.
More ▼
- Axogen, Inc. Reports Fourth Quarter and Full-Year 2025 Financial Results
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
- Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock
- Axogen Announces Proposed Public Offering of Common Stock
- Axogen, Inc. Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2025
- Axogen, Inc. to Participate in the J.P. Morgan 2026 Healthcare Conference
- Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)
- Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
- Axogen, Inc. Reports Third Quarter 2025 Financial Results
More ▼
